What can the European Multicenter Trial on the treatment of Graves' disease with antithyroid drugs teach us about the course of thyroid-associated orbitopathy (TAO)? European Multicenter Trial Group

Exp Clin Endocrinol Diabetes. 1999:107 Suppl 5:S186-9. doi: 10.1055/s-0029-1212182.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aging / physiology
  • Antithyroid Agents / therapeutic use*
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Eyeglasses
  • Graves Disease / drug therapy*
  • Graves Disease / physiopathology
  • Graves Disease / therapy
  • Humans
  • Middle Aged
  • Prevalence

Substances

  • Antithyroid Agents